Observed Signal · Oct 27, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 2/5 · Sentiment: Positive
Vera Health Raises $28.5M for Clinical AI Search
Vera Health, a clinical AI search engine for physicians, announced a $28.5 million Series A funding round led by Threshold Ventures, with participation from Optum Ventures, Mantis VC, and SV Angel. Existing investors Y Combinator and Gradient increased their backing, bringing Vera's total funding to $32 million. The platform, co-founded by Maxime Allouch and Taieb Bennani, helps clinicians find and evaluate medical evidence from over 60 million scientific publications, clinical guidelines, and drug labels. It is used by more than 800,000 clinicians across 190 countries. The company plans to use the funding to expand internationally, particularly in Europe, and to deepen integration with health systems and medical societies. Vera is free for clinicians and monetizes through institutional subscriptions and partnerships.
Funding for a clinical AI platform is relevant to the AdTech/MarTech/AI industry due to its use of AI and data-driven technologies, but it is not core to advertising technology or marketing.
Track SV Angel Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Vera Health raised a $28.5 million Series A led by Threshold Ventures, with participation from Optum Ventures, Mantis VC, and SV Angel.
- Existing investors Y Combinator and Gradient increased their backing, bringing total funding to $32 million.
- The platform is used by more than 800,000 clinicians across 190 countries.
- Vera Health searches over 60 million scientific publications, clinical guidelines, and drug labels.
- The company has made its first European hire in Berlin and plans to expand further in Europe.
Connected Companies & Entities
“SV Angel participated in the Series A funding round.”
“Existing investor Y Combinator increased its backing in the round.”
“Optum Ventures is the healthcare venture firm backed by UnitedHealth Group.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Verda Raises $189M to Expand AI Cloud and Compute Capacity
European AI cloud company Verda, formerly DataCrunch, has raised $189 million (€164.8 million) in Series B funding, propelling it to unicorn status with a valuation over $1 billion. The oversubscribed round was led by Emergence Capital, with participation from MUFG Innovation Partners, Supermicro, Varma, Lifeline Ventures, 6 Degrees Capital, byFounders, Tesi, and angel investors including Ola Tørudbakken and Mark Saroufim. This brings Verda's total funding to over $450 million (€392.3 million). The company plans to scale its full-stack AI cloud, accelerate product development, multiply compute capacity, and expand internationally, including deploying Nvidia's upcoming VR200 NVL72 generation. Verda's renewable-powered data centres in Finland support its operations across Europe, the US, and Asia. The company reported an annualized revenue run rate of $165 million (€143.85 million) in July 2026, serving customers in over 50 countries.
Havas Invests in AI Research Platform, Enhances Client Insights
Vurvey Labs, an AI-powered research platform, announced $8.5 million in Series A funding led by Havas, which also becomes a customer and partner. The deal ties Vurvey to Havas through client recommendations, board representation, and integration across Havas' health and creative divisions. Vurvey's core offering is a 'people model'—a large-scale AI model trained on millions of customer interviews to generate AI agents and populations reflecting diverse personalities and behaviors. Training relies on self-recorded video interviews rather than text Q&As, capturing emotions and mannerisms. The company also uses first- and third-party data from social platforms and a brand's internal data. Havas Health uses Vurvey to create synthetic doctor personas for pharma clients, helping understand reactions to dosing approaches and accelerating scenario testing from weeks to minutes. The approach aims to preserve human insight while scaling interviewing across populations, per founder Chad Reynolds and Havas executives.
XRlabs Raises €7.48M for AI Surgical Intelligence
London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).
Receive all future signals for SV Angel & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.